TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Translational research on immune checkpoint inhibitors (ICIs) has been underway. However, in the unselected population, only a few patients benefit from ICIs. Therefore, screening predictive markers of ICI efficacy has become the current focus of attention. We collected mutation and clinical data fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Anqi, Zhang, Hongman, Meng, Hui, Deng, Ze, Gu, Tianqi, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481577/
https://www.ncbi.nlm.nih.gov/pubmed/34603277
http://dx.doi.org/10.3389/fimmu.2021.667875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481577/
https://www.ncbi.nlm.nih.gov/pubmed/34603277
http://dx.doi.org/10.3389/fimmu.2021.667875

Ejemplares similares